INJECTION SITE INJURY

This adverse event was reported 5550 times

These drugs are most commonly taken by patients reporting INJECTION SITE INJURY:

# Drug Count
0 TIRZEPATIDE 1527
1 ADALIMUMAB 603
2 DULAGLUTIDE 363
3 ETANERCEPT 311
4 INSULIN GLARGINE 279
5 GALCANEZUMAB-GNLM 204
6 METFORMIN 184
7 METFORMIN ER 500 MG 181
8 METFORMIN ER 750 MG 181
9 TERIPARATIDE 175
See all common drugs associated with INJECTION SITE INJURY

INJECTION SITE INJURY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRALIDOXIME CHLORIDE 4 0.1538
1 TIRZEPATIDE 1527 0.0084
2 ADALIMUMAB-ADBM 2 0.0075
3 GALCANEZUMAB-GNLM 204 0.0063
4 TESTOSTERONE ENANTHATE 8 0.0049
5 DULAGLUTIDE 363 0.0041
6 PEGVISOMANT 16 0.0039
7 ADALIMUMAB-ATTO 4 0.0025
8 ERGOCALCIFEROL 65 0.0022
9 BETAMETHASONE VALERATE FOAM 9 0.0020
See all drugs enriched for association with INJECTION SITE INJURY

INJECTION SITE INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 13 0.0189
1 PCSK9 Inhibitor [EPC] 172 0.0067
2 GLP-1 Receptor Agonist [EPC] 1956 0.0044
3 Interleukin-17A Antagonist [EPC] 129 0.0035
4 Adrenocorticotropic Hormone [EPC] 3 0.0034
5 Sclerosing Agent [EPC] 1 0.0022
6 Provitamin D2 Compound [EPC] 65 0.0022
7 Parathyroid Hormone Analog [EPC] 175 0.0016
8 Catecholamine [EPC] 114 0.0014
9 Insulin [EPC] 63 0.0014
See all drug classes enriched for association with INJECTION SITE INJURY